Ingelheim, Germany

Kerstin Schlarb

This inventor holds 4 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2007-2013.


% Patents Active = 100.0



Average Co-Inventor Count = 7.0

ph-index = 4

Forward Citations = 27(Granted Patents)


Location History:

  • Ingelheim, DE (2007 - 2008)
  • Baerweiler, DE (2011)
  • Appenheim, DE (2013)

Company Filing History:


Years Active: 2007-2013

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Journey of Kerstin Schlarb

Introduction

Kerstin Schlarb is a prominent inventor based in Ingelheim, Germany. She has made significant contributions to the field of chemistry, particularly in the development of pharmaceutical compounds. With a total of 4 patents to her name, her work has had a notable impact on the industry.

Latest Patents

Among her latest patents are two innovative processes related to the preparation of 4-(benzimidazolylmethylamino)-benzamides and their salts. The first patent describes a process for preparing an optionally substituted 4-benzimidazol-2-ylmethylamino)-benzamidine. The second patent focuses on the preparation of the salts of these compounds, showcasing her expertise in chemical synthesis and formulation.

Career Highlights

Kerstin has worked with renowned companies such as Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in pharmaceutical research and development.

Collaborations

Throughout her career, Kerstin has collaborated with notable colleagues, including Heinz-Peter Schmitt and Arndt Hausherr. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Kerstin Schlarb's contributions to the field of chemistry and her innovative patents highlight her role as a leading inventor. Her work continues to influence the pharmaceutical industry, paving the way for future advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…